De ce ia Sam Altman Metformină
GeoGazet Informații· Actualizat 5 oct. 2026· 1 min lectură· 484 vizualizări
There is no credible evidence that Sam Altman, OpenAI's CEO since 2019, takes metformin.
This claim lacks substantiation in public records, health disclosures, or verified reporting.
Altman's health information remains private.
Citiți raportul completArătați mai puțin
De ce ia Sam Altman Metformină
Public Focus on AI Development
Altman's documented activities center on OpenAI's product roadmap. Recent initiatives include OpenAI Dots, his unveiled ChatGPT AI personal agent, alongside the 2026 DevDay announcements. His tracked signals show 94 connections to Artificial Intelligence developments.
Speculation Without Basis
Health rumors about prominent figures often circulate online without verification. Without direct statements from Altman or credible medical sources, claims about his medications should be treated as unsubstantiated speculation rather than fact.
Urmărește Altman în direct.Fiecare actualizare se postează pe Telegram-ul nostru.
Alăturați-vă pe TelegramRecenzii ale cititorilor
Nicio recenzie încă. Fiți primul care vă împărtășiți opinia.